About this trial
This clinical trial develops a chatbot smartphone application (app), QuitBot, and text messaging to help American Indians (AI) and Alaska Natives (AN) to quit smoking commercial tobacco (smoking cessation), and evaluates two remote smoking cessation programs to see how well they work for helping AI/AN people quit smoking commercial tobacco. AI/AN populations have one of the highest rates of commercial cigarette smoking of any racial and ethnic group in the United States (US). They also have a higher rate of developing smoking-related cancer but are less likely to quit smoking. The two programs are designed to provide personalized support in setting a smoking cessation goal, tasks to reach the smoking cessation goal, and motivation to remain smoke-free. This may help to keep participants engaged and support them in their quit efforts, and may improve smoking cessation among AI and AN.
Eligibility criteria
Qualifiers
Self-identifying as American Indian or Alaska Native, either alone or in combination with other races
Age 18 and older
Smoking combustible cigarettes daily in the past year
Interest in quitting smoking
Disqualifiers
The reverse of the inclusion criteria
Pregnant or breastfeeding
Use of other tobacco products (e.g., ceremonial use of tobacco, e-cigarettes) will be assessed but is not an exclusion criterion, as it would limit the study's generalizability
Trial design
Treatments tested in this trial
- QuitBot Smoking Cessation Chatbot Program
- QuitBot Smoking Cessation Text Messaging Program
- Survey Administration
- Interview
- Carbon Monoxide Measurement
Treatment groups
Sponsors and collaborators
Fred Hutchinson Cancer Center
Lead sponsor
National Institute on Minority Health and Health Disparities (NIMHD)
Collaborator